Colorectal Cancer clinical trials
Showing 251–300 of 533 active trials. Describe your situation to see which ones you may be eligible for.
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
- A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- A Study of DM005 in Patients With Advanced Solid Tumors
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- AMT-116 in Patients With Advanced Solid Tumors
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- A Study of MGC028 in Participants With Advanced Solid Tumors
- A Beta-only IL-2 ImmunoTherapY Study
- A Phase 1/1b Study of IAM1363 in HER2 Cancers
- A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
- A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- Reducing Metabolic Dysregulation in Dyads
- The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
- Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
- COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
- Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
- Pilot Testing of a Colorectal Cancer Education Program
- Efficacy and Safety of the CG-100 Intraluminal Bypass Device
- A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
- Low Pressure Pneumoperitoneum and Postoperative Ileus
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- Building Connections
- Colorectal Cancer Screening Outreach
- Impact of Protect Your Colon™ on CRC Screening
- Bundled Cancer Screening and Genetic Services Navigation
- Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
- Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
- Evaluation of Gixam's Performance in a FIT Negative Population
- Community Partnership for Telehealth Solutions to Convey Information and Enhance Care
- Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.